Company / Working Capital
enGene Holdings Inc. Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$169.4M
FY2025
5-year range
$17.5M / $232.7M
FY2022-FY2025
Trend
-27.2%
vs FY2024
Sector context
#175 of 214
Health Care
What the data says
enGene Holdings Inc.'s working capital of $169M is lower than 82% of companies in the Health Care sector (FY2025). Improved from $80M to $169M over the past 2 years.
Based on SEC 10-K filings.
$169M in FY2025 with a 3-year CAGR of +113.2%.
Improved from $80M to $169M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +113.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 214This company $169.4M Sector average $955.5M
▼
-82.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +113.2%, indicating consistent growth.
- In FY2025, working capital decreased 27.2% year-over-year.
- Ranks #175 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $169.4M | -27.2% |
| FY2024 | $232.7M | +190.2% |
| FY2023 | $80.2M | +358.7% |
| FY2022 | $17.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026